Literature DB >> 30470957

Effect of RAB31 silencing on osteosarcoma cell proliferation and migration through the Hedgehog signaling pathway.

Qiong Yu1, Dong Li2, Dan Wang3, Chun-Mei Hu1, Yan Sun1, Yan Tang1, Guang Shi4.   

Abstract

Osteosarcoma (OS) is a prevalent cancer that plagues people worldwide. Identifying prognostic markers would be useful in treating human OS. In this study, we aimed to explore the functions of Ras-related protein Rab-31 (RAB31) in OS-cell proliferation, migration, and invasion as well as its roles in the Hedgehog signaling pathway for better understanding of the mechanism. To assess the detailed regulatory mechanism of RAB31 silencing on OS, both RT-qPCR and Western blot analysis were employed to evaluate the expressions of RAB31 as well as the Hedgehog signaling pathway-related genes. Besides, we also investigated the effects of silenced RAB31 both in vitro and in vivo. First, we found that in OS tissues, both mRNA and protein expressions of RAB31 and PCNA had a significant increase. Second, the Hedgehog signaling pathway was detected to play an integral role in OS progression. Finally, after transfection of RAB31-siRNA to reduce the expression of RAB31, the Hedgehog signaling pathway was suppressed, along with cell proliferation, invasion, and migration. Therefore, we conclude that RAB31 plays an important role in OS development and its silencing delays the OS progression via suppression of the Hedgehog signaling pathway.

Entities:  

Keywords:  Hedgehog signaling pathway; Invasion; Osteosarcoma; Proliferation; RAB31

Mesh:

Substances:

Year:  2018        PMID: 30470957     DOI: 10.1007/s00774-018-0961-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  39 in total

1.  HMGB1 promotes drug resistance in osteosarcoma.

Authors:  Jun Huang; Jiangdong Ni; Ke Liu; Yan Yu; Min Xie; Rui Kang; Philip Vernon; Lizhi Cao; Daolin Tang
Journal:  Cancer Res       Date:  2011-11-18       Impact factor: 12.701

2.  Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases.

Authors:  Jörg Warzecha; Daniela Dinges; Balasz Kaszap; Dirk Henrich; Ingo Marzi; Caroline Seebach
Journal:  Int J Mol Med       Date:  2011-12-01       Impact factor: 4.101

3.  Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.

Authors:  Yu Wang; Lei Li; Naimin Shao; Zhiqi Hu; Hui Chen; Leqin Xu; Changping Wang; Yiyun Cheng; Jianru Xiao
Journal:  Acta Biomater       Date:  2015-01-14       Impact factor: 8.947

4.  Expression of survivin and correlation with PCNA in osteosarcoma.

Authors:  Wenji Wang; Huiying Luo; Aiqin Wang
Journal:  J Surg Oncol       Date:  2006-06-01       Impact factor: 3.454

5.  PTCH1, a receptor of Hedgehog signaling pathway, is correlated with metastatic potential of colorectal cancer.

Authors:  Sihong You; Jiannong Zhou; Senqing Chen; Ping Zhou; Jinghuan Lv; Xiao Han; Yujie Sun
Journal:  Ups J Med Sci       Date:  2010-08       Impact factor: 2.384

6.  Inhibition of osteosarcoma cell proliferation by the Hedgehog-inhibitor cyclopamine.

Authors:  J Warzecha; S Göttig; K U Chow; C Brüning; D Percic; S Boehrer; E Brude; A Kurth
Journal:  J Chemother       Date:  2007-10       Impact factor: 1.714

7.  Expression of glioma-associated oncogene homolog 1 is associated with invasion and postoperative liver metastasis in colon cancer.

Authors:  Yin-lu Ding; Yong Zhou; Lei Xiang; Zhi-peng Ji; Zhou-hong Luo
Journal:  Int J Med Sci       Date:  2012-06-21       Impact factor: 3.738

8.  Radiotherapy in the treatment of primary osteosarcoma--a single center experience.

Authors:  Susanne Oertel; Claudia Blattmann; Stefan Rieken; Alexandra Jensen; Stephanie E Combs; Peter E Huber; Mark Bischof; Andreas Kulozik; Jürgen Debus; Daniela Schulz-Ertner
Journal:  Tumori       Date:  2010 Jul-Aug

9.  Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma.

Authors:  Christophe Paget; Helene Duret; Shin Foong Ngiow; Maya Kansara; David M Thomas; Mark J Smyth
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

10.  miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.

Authors:  Dawei Yang; Guangpeng Liu; Kunzheng Wang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more
  3 in total

1.  Rab31 promotes the invasion and metastasis of cervical cancer cells by inhibiting MAPK6 degradation.

Authors:  Yujie Huang; Ruijuan Liu; Xuechao Han; Xiaoyan Hou; Yonghao Tian; Weifang Zhang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

2.  Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells.

Authors:  Thomas Kirchner; Viktor Magdolen; Susanne Soelch; Nathalie Beaufort; Daniela Loessner; Matthias Kotzsch; Ute Reuning; Thomas Luther
Journal:  Mol Med       Date:  2021-12-14       Impact factor: 6.354

3.  CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions.

Authors:  Yangke He; Hui Huang; Li Jin; Fang Zhang; Ming Zeng; Liang Wei; Shijia Tang; Dongqin Chen; Wansheng Wang
Journal:  Cell Death Dis       Date:  2020-05-12       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.